Pain management

Anaesthesia

Volumn 58, Issue 12, 2003, Pages 1196-1199

  Rowbotham, David J ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ RECEPTOR; CANNABINOID; CANNABIS; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; ETORICOXIB; GABAPENTIN; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; ION CHANNEL; KETAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; PARACETAMOL; PARECOXIB; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; SUBSTANCE P; SUBSTANCE P ANTAGONIST; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG; VALDECOXIB;

ALLODYNIA; CHRONIC PAIN; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DIABETIC NEUROPATHY; DIGESTIVE SYSTEM ULCER; DORSAL ROOT; DRUG ACTIVITY; DYSPHORIA; HEART INFARCTION; HUMAN; INCIDENCE; INFLAMMATION; LIVER TOXICITY; LUNG EMBOLISM; LUNG INFECTION; META ANALYSIS; MOBILIZATION; NAUSEA; NERVE SPROUTING; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NOCICEPTION; PAIN; PATIENT CONTROLLED ANALGESIA; PATIENT SATISFACTION; POSTHERPETIC NEURALGIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PROSTAGLANDIN SYNTHESIS; REHABILITATION CENTER; RESPIRATION DEPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SENSITIZATION; SIDE EFFECT; TREATMENT FAILURE;

ANALGESIA; ANALGESIA, EPIDURAL; HUMANS; PAIN CLINICS; PAIN, POSTOPERATIVE;

EID: 0345116139     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2003.03567.x     Document Type: Review

References (39)

1. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1 beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001; 410: 471-5.
2. Burgess GM, Perkins MN, Rang HP, et al. Bradyzide, a potent non-peptide B2 bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia. British Journal of Pharmacology 2000; 129: 77-86.
3. Opree A, Kress M. Involvement of the proinflammatory cytokines tumor necrosis factor-α, IL-1α and IL-6 but not IL-8 in the development of heat hyperalgesia: Effects on heat-evoked calcitonin gene-related peptide release from rat skin. Journal of Neuroscience 2000; 20: 6289-93.
4. Mani RN, Breedveld FC, Kalden JR, et al. Therapeutic efficacy if multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with methotrexate in rheumatoid arthritis. Arthritis and Rheumatism 1998; 41: 1552-63.
5. Hill R. NK-1 (substance P) antagonists - Why they are not analgesics in humans? Trends in Pharmacological Sciences 2000; 21: 244-6.
6. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983; 306: 686-8.
7. Woolf CJ, Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proceedings of the National Academy of Sciences 1999; 96: 7723-30.
8. Bridges D, Thompson SWN, Rice ASC. Mechanisms of neuropathic pain. British Journal of Anaesthesia 2001; 87: 12-26.
9. Woolf CJ, Mannion RJ. Pain: Neuropathic pain. Aetiology, symptoms, mechanisms and management. Lancet 1999; 353: 1959-64.
10. Woolf CJ, Shortland P, Coggeshall RE. Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 1992; 355: 75-8.
11. Koerber HR, Mirnics K, Brown PB, Mendell LM. Central sprouting and functional plasticity of regenerated primary afferents. Journal of Neuroscience 1994; 14: 3655-71.
12. Darland T, Heinricher MM, Grandy DK. Orphanin FQ/nociceptin. A role in pain and analgesia, but so much more. Trends in Neurosciences 1998; 21: 215-21.
13. Calo G, Guerrini R, Rizzi A, Salvadori S, Regoli D. Pharmacology of nociceptin and its receptor: A novel therapeutic target. British Journal of Pharmacology 2000; 129: 1261-83.
14. Wright KE, Mcdonald J, Barnes TA, et al. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells. Neuroscience Letter 2003; 346: 145-8.
15. Clemett D, Goa KL. Celecoxib: A review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Drugs 2000; 59: 957-80.
16. Matheson AJ, Figgitt DP. Rofecoxib: A review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis. Drugs 2001; 61: 833-65.
17. Alsalameh S, Burian M, Mahr G, Woodcock BG, Geisslinger G. Review article. The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor. Alimentary Pharmcology and Therapeutics 2003; 17: 489-501.
18. Hubbard RC, Naumann TM, Traylor L, Dhadda S. Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia. British Journal of Anaesthesia 2003; 90: 166-72.
19. Patrignani P, Capone ML, Tacconelli S. Clinical pharmacology of etoricoxib: A novel selective COX-2 inhibitor. Expert Opinion on Pharmacotherapy 2003; 4: 265-84.
20. Rowbotham DJ. Cox 2 specific inhibitors. Clinical relevance in surgical and acute pain. European Journal of Anaesthesiology 2002; 19 (Suppl. 25): 11-20.
21. Lipsky PE, Brooks P, Crofford LJ, et al. Unresolved issues in the role of cyclo-oxygenase-2 in normal physiologic process and disease. Archives of Internal Medicine 2000; 160: 913-20.
22. Chandrasekharan NV, Dai H, Roos KLT, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetominophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. PNAS 2002; 99: 13926-31.
23. Ware MA, Doyle CR, Woods R, Lynch ME, Clark AJ. Cannabis use for chronic non-cancer pain: Results of a prospective survey. Pain 2003; 102: 211-16.
24. Hart EM, Doherty WL, Sharpe P, Lambert DG, Buggy DJ, Rowbotham DJ. An open-labelled, dose-finding study of the analgesic and side-effects of a cannabis-based medicine extract in a model of postoperative pain. British Journal of Anaesthesia 2002; 88: 321.
25. Croxford JL. Therapeutic potential of cannabinoids in CNS disease. CNS Drugs 2003; 17: 179-2002.
26. Buggy DJ, Toogood L, Maric S, Sharpe P, Lambert DG, Rowbotham DJ. Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain. Pain 2003; in press.
27. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Postherpetic Neuralgia Study Group. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. Journal of the American Medical Association 2001; 94: 215-24.
28. Rice ASC, Maton S. Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo ontrolled study. Pain 2001; 94: 215-24.
29. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment in painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. Journal of the American Medical Association 1998; 280: 1831-6.
30. Clinical Standards Advisory Group. Services for Patients with Pain. London: Her Majesty's Stationery Office, 2000.
31. Macintyre PE. Safety and efficacy of patient-controlled analgesia. British Journal of Anaesthesia 2001; 87: 36-46.
32. Dahlgren N, Tornebrandt K. Neurological complications after anaesthesia. A follow-up of 18,000 spinal and epidural anaesthetics performed over three years. Acta Anaesthesiologica Scandinavica 1995; 39: 872-80
33. Aromaa U, Lahdensuu M, Cozanitis DA. Severe complications associated with epidural and spinal anaesthesias in Finland 1987-93. A study based on patient insurance claims. Acta Anaesthesiologica Scandinavica 1997; 41: 445-52.
34. Giebler RM, Scherer RU, Peters J. Incidence of neurologic complications related to thoracic epidural catheterization. Anesthesiology 1997; 86: 55-63.
35. Rodgers A, Walker N, Shug S, et al. Reduction of postoperative mortality andn morbidity with epidural or spinal anaesthesia. Results from overview of randomised trails. British Medical Journal 2000; 321: 1493-7.
36. Kehlet H, Kolte K. Effect of postoperative analgesia on surgical outcome. British Journal of Anaesthesia 2001; 87: 62-72.
37. Macrae WA. Chronic pain after surgery. British Journal of Anaesthesia 2001; 87: 88-98.
38. Bay-Nielsen M, Perkins FM, Kehlet H. Pain and functional impairment 1 year after inguinal herniorrhaphy: A nationwide questionnaire study. Annals of Surgery 2001; 233: 1-7.
39. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery: A review of predictive factors. Anesthesiology 2000; 93: 1123-33.